C. Magis-Escurra (Nijmegen, Netherlands), O. Kon (London, United Kingdom), J. Eimer (London, United Kingdom)
Regional study on the management and coutcomes of Tuberculous Uveitis
S. Alderazi (Birmingham, United Kingdom), O. Akpenyi (Birmingham, United Kingdom), G. Hagan (Birmingham, United Kingdom), N. Nathani (Birmingham, United Kingdom)
|   |
A Case Series of Pericardial TB in a large European Centre
A. Sundaralingam (London, United Kingdom), Y. Kilic (London, United Kingdom), M. Burman (London, United Kingdom), A. Rahman (London, United Kingdom), V. White (London, United Kingdom), N. Jayasekera (London, United Kingdom), M. Darmalingam (London, United Kingdom), S. Tiberi (London, United Kingdom), H. Kunst (London, United Kingdom)
| |
Antituberculosis drug- induced hepatitis, an unpredictable phenotype
M. da Silva Alcobia (Coimbra, Portugal), L. M Nogueira (Coimbra, Portugal), B. Oliveiros (Coimbra, Portugal), C. Robalo Cordeiro (Coimbra, Portugal), H. C Silva (Coimbra, Portugal)
| |
Utility of Xpert® MTB/RIF assay for extrapulmonary tuberculosis, a two year study
R. Agrawal (Bareilly, India), R. Agarwal (Bareilly, India), U. Gupta (Bareilly, India)
| |
The utility of Xpert MTB/RIF in the diagnosis of Tubercular Mediastinal Lymphadenopathy by Endobronchial Ultrasound.
R. Gupta (Ghaziabad, India), A. Bhatia (Ghaziabad, India), S. Joshi (Ghaziabad, India), N. Tayal (Ghaziabad, India), P. Pandey (Ghaziabad, India), A. Gupta (Ghaziabad, India)
| |
Sensitivity and Specificity of Cartridge Based Nucleic Acid Amplification Test in pleural biopsy obtained by thoracoscopy.
D. Muthreja (Nagpur, India), R. Swarnakar (Nagpur, India), A. Sontakke (Nagpur, India)
| |
Safety of bedaquiline for treatment of MDR/XDR tuberculosis in HIV co-infected patients
A. Galstyan (Moscow, Russian Federation), S. Borisov (Moscow, Russian Federation), M. Sinitsyn (Moscow, Russian Federation), D. Ivanova (Moscow, Russian Federation), L. Slogodskay (Moscow, Russian Federation)
| |
Mycobacterium tuberculosis detection rates by molecular genetic methods among patients with tuberculosis in the Russian Federation.
E. Veselova (Moscow, Russian Federation), A. Panova (Moscow, Russian Federation), G. Kaminskiy (Moscow, Russian Federation), V. Testov (Moscow, Russian Federation), A. Samoilova (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation)
| |
Drug resistance and HIV rates are high in Eastern European patients with Tuberculosis in a South East London Hospital
S. Ratnakumar (london, United Kingdom), X. Choon (london, United Kingdom), M. Belton (london, United Kingdom), P. Palchaudhuri (london, United Kingdom), L. Cotton (london, United Kingdom)
| |
The peculiarities of drug susceptibility of M. tuberculosis isolated from patients with late-stage HIV infection
N. Karpina (Moscow, Russian Federation), A. Dudchenko (Moscow, Russian Federation), E. Larionova (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation)
| |
Impact of seasons on tuberculosis mortality for HIV+ and HIV- TB patients
O. Chizhova (Moscow, Russian Federation), E. Belilovskiy (Moscow, Russian Federation), S. Borisov (Moscow, Russian Federation), M. Sinitsyn (Moscow, Russian Federation)
| |
Hospitalized tuberculosis: HIV versus non-HIV patients
M. Martins de Matos Navarro Guia (Lisbon, Portugal), M. Caixeiro (Lisbon, Portugal), J. Boléo-Tomé (Lisbon, Portugal), P. Pacheco (Lisbon, Portugal), F. Rodrigues (Lisbon, Portugal)
| |
Burden of the primary drug resistance of Mycobacterium tuberculosis in HIV-positive patients
A. Panova (Moscow, Russian Federation), V. Testov (Moscow, Russian Federation), G. Kaminskiy (Moscow, Russian Federation), A. Samoilova (Moscow, Russian Federation), E. Veselova (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation)
| |
Clinical, immunological and epidemiological correlations of Tuberculosis / HIV Coinfection in patients Infected with HIV in Olt County in Romania between 2005-2015
C. Calarasu (Craiova, Romania), F. Nitu (Craiova, Romania), F. Dumitrescu (Craiova, Romania), V. Grecu (Craiova, Romania)
| |
Treatment tactics in patients with tuberculous pleurisy
N. Chernyh (Moscow , Russian Federation), M. Tikhonova (Moscow , Russian Federation), A. Polyakova (Moscow , Russian Federation), V. Romanov (Moscow , Russian Federation), R. Amansahedov (Moscow , Russian Federation)
| |
Anti-tubercular drug concentrations in Pulmonary Tuberculosis patients - Diabetic vs Non-Diabetic groups.
D. Christopher (Vellore, India), D. Jedidiah (Vellore, India), B. Isaac (Vellore, India), B. Mathew (Vellore, India), B. Winston (Vellore, India)
| |
Effectiveness of mesodiencephalic modulation in treatment of XDR TB patients with concomitant type II diabetes mellitus
N. Chernyh (Moscow , Russian Federation), M. Tikhonova (Moscow , Russian Federation), V. Romanov (Moscow , Russian Federation), A. Polyakova (Moscow , Russian Federation)
| |
Efficacy of treatment in MDR and XDR lung TB patients in the follow-up period with the use of new anti-tuberculosis agent
A. Starshinova (St.-Petersburg, Russian Federation), E. Beliaeva (St.-Petersburg, Russian Federation), M. Nazarenko (St.-Petersburg, Russian Federation), M. Pavlova (St.-Petersburg, Russian Federation), I. Chernochaeva (St.-Petersburg, Russian Federation), P. Yablonskiy (St.-Petersburg, Russian Federation)
| |
Clinical relevance of differentiation between Mycobacterium avium and M. intracellulare in M. avium complex pulmonary disease in Croatia
G. Glodic (Zagreb, Croatia), I. Sabol (Zagreb, Croatia), L. Zmak (Zagreb, Croatia), A. Šola (Zagreb, Croatia), A. Marušic (Zagreb, Croatia), A. Hecimovic (Zagreb, Croatia), F. Džubur (Zagreb, Croatia), M. Jakopovic (Zagreb, Croatia), L. Kardum Bulat (Rijeka, Croatia), G. Pavliša (Zagreb, Croatia), M. Samaržija (Zagreb, Croatia), A. Civljak (Zagreb, Croatia), A. Dakic (Zagreb, Croatia), M. Jankovic Makek (Zagreb, Croatia)
| |